Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sonazoid vs SonoVue for Focal Liver Lesions
NCT03335566Phase 3Completed
- Sponsor
- GE HealthCare
- Start
- May 2014
- Primary completion
- Apr 2015
- Modality
- Nanoparticles
- Countries
- 3
01
Overview
A Phase 3 trial of sonazoid in focal liver lesions (FLLs), sponsored by GE HealthCare. Started May 2014; status: completed.
02
Drugs
sonazoid
03
Conditions
focal liver lesions (FLLs)
Beyond the preview
Go deeper on NCT03335566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03335566.